Density of antibiotic use and infectious complications in pediatric allogeneic hematopoietic cell transplantation. Issue 2 (22nd February 2023)

• Record Type: Journal Article
• Authors: Andrew, Eden C.; Khaw, Seong Lin; Hanna, Diane; Conyers, Rachel; Fleming, Jacqueline; Hughes, David; Toro, Claudia; Wang, Stacie Shiqi; Weerdenburg, Heather; Anderson, Sally; Cole, Theresa; Haeusler, Gabrielle M
• Is Part Of: Transplant infectious disease. Volume 25:Issue 2(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2023-02-22
• Subjects: antibiotics -- infections -- microbiome -- pediatrics -- stem‐cell transplantation; Transplantation of organs, tissues, etc -- Complications -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 617.01
• DOI: 10.1111/tid.14018
• Languages: English
• ISSNs: 1398-2273

Abstract

Abstract: Background: Antibiotics, while an essential component of supportive care in allogeneic hematopoietic cell transplantation (allo‐HCT), can have adverse effects and select for antibiotic resistance. Understanding of patterns of use will inform antimicrobial stewardship (AMS) interventions. Methods: Retrospective, single‐center cohort of children undergoing first allo‐HCT ( n = 125). Antibiotic prescription and infection data were included from the date conditioning was commenced until 30 days post allo‐HCT. Antibiotic use was reported as length of therapy (LOT) (number of days a patient received an antibiotic) and days of therapy DOT (aggregating all antibiotics prescribed per day). Infections were classified as microbiologically documented infection (MDI) or clinically documented infections. Results: At least one course of antibiotics was administered to 124 (99%) patients. The LOT was 636 per 1000 patient days and DOT was 959 per 1000 patient days. The median duration of cumulative antibiotic exposure per patient was 24 days (interquartile range [IQR] 20–30 days). There were 131 days of fever per 1000 patient days with patients febrile for a median of 4 days (IQR 1–7 days). Piperacillin–tazobactam was used for 116 (94%) of patients with an LOT of 532 per 1000 patient days. A total of 119 MDI episodes occurred in 74 (59%) patients, including blood stream infection in 30 (24%) and a proven/probable invasive fungal infection in 4 (3%). Conclusion: Pediatric HCT patients receive prolonged courses of broad‐spectrum antibiotics relative to the frequency of fever and bacterial infections. This study has identified opportunities for AMS intervention to improve outcomes for our HCT patients. Abstract :